Abeona Therapeutics Inc. (ABEO) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $4.33 (-4.93%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 17, 2026 | Stephen Willey | Stifel Nicolaus | $17.00 | +292.2% |
| May 16, 2025 | Stephen Willey | Stifel Nicolaus | $20.00 | +361.4% |
Top Analysts Covering ABEO
ABEO vs Sector & Market
| Metric | ABEO | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.41 |
| Analyst Count | 3 | 8 | 19 |
| Target Upside | +307.6% | +153002.0% | +21.5% |
| P/E Ratio | 4.27 | 3.47 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $11M | $25M | $44M | 3 |
| 2027-03-31 | $11M | $25M | $43M | 3 |
| 2027-06-30 | $14M | $31M | $53M | 2 |
| 2027-09-30 | $17M | $39M | $67M | 2 |
| 2027-12-31 | $21M | $46M | $80M | 3 |
| 2028-12-31 | $242M | $245M | $249M | 4 |
| 2029-12-31 | $182M | $297M | $393M | 3 |
| 2030-12-31 | $218M | $357M | $473M | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.17 | $-0.09 | $-0.02 | 1 |
| 2027-03-31 | $-0.25 | $-0.13 | $-0.04 | 1 |
| 2027-06-30 | $-0.11 | $-0.06 | $-0.02 | 1 |
| 2027-09-30 | $0.01 | $0.05 | $0.09 | 1 |
| 2027-12-31 | $0.04 | $0.14 | $0.27 | 1 |
| 2028-12-31 | $0.64 | $1.14 | $2.20 | 4 |
| 2029-12-31 | $0.79 | $1.60 | $2.28 | 2 |
| 2030-12-31 | $1.02 | $2.06 | $2.93 | 2 |
Frequently Asked Questions
What is the analyst consensus for ABEO?
The consensus among 3 analysts covering Abeona Therapeutics Inc. (ABEO) is Buy with an average price target of $17.67.
What is the highest price target for ABEO?
The highest price target for ABEO is $20.00, set by Stephen Willey at Stifel Nicolaus on 2025-05-16.
What is the lowest price target for ABEO?
The lowest price target for ABEO is $17.00, set by Stephen Willey at Stifel Nicolaus on 2026-03-17.
How many analysts cover ABEO?
3 analysts have issued ratings for Abeona Therapeutics Inc. in the past 12 months.
Is ABEO a buy or sell right now?
Based on 3 analyst ratings, ABEO has a consensus rating of Buy (2.00/5) with a +307.6% upside to the consensus target of $17.67.
What are the earnings estimates for ABEO?
Analysts estimate ABEO will report EPS of $-0.09 for the period ending 2026-12-31, with revenue estimated at $25M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.